The European Chemicals Agency (ECHA) is consulting on new harmonised classification and labelling (CLH) proposals for citric acid and clomazone.
Citric acid, an active substance in the EU Biocidal Products Regulation 528/2012 has been proposed by Belgium for a new entry in Annex VI on the classification, labelling and packaging of substances and mixtures (CLP) Regulation for Skin Irrit. 2, H315; Eye Irrit. 2, H319; STOT SE 3, H335 (CLH report). Citric acid is approved as Product Type 2 for use in three-ply tissues of which the middle layer is impregnated with citric acid (7.5%). Citric acid is intended to inactivate the viral load within the tissue after it has been used in order to prevent transfer back to the hands, transmittance of the virus from hand-to-hand contact and transmittance to surfaces with which the tissue comes into contact.
Clomazone proposed by the Netherlands for a new entry in Annex VI of the CLP Regulation for Acute Tox. 4, H302; ATE = 754mg/kg bw; Acute Tox. 4, H332; ATE = 4.3mg/L; Repr. 1B, H360D; Aquatic Acute 1, H400, Aquatic Acute 1, M-factor = 1; Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor = 1 (CLH report).
Comments should be received by 8 February 2019 through the individual substance links at the ECHA website.
Following the inclusion of the substance in Part 3 of Annex VI to the CLP Regulation, all manufacturers, importers and downstream users of the substance in the EU must classify the substance in accordance with the entry in Annex VI (Article 4(3) of the CLP Regulation).
Last reviewed 6 December 2018